Latest filing published 31 May 2024 for Shockwave Medical, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Isaac Zacharias (chief executive) discloses dealings in Shockwave Medical, Inc. to SEC (Form 4). We count 212 filings; the first trade dates from 17 April 2019 and the latest from 31 May 2024.
No open-market purchase appears, only 132 sales worth €33.2M. Other entries cover 36 share grants and 43 option exercises. Since January 2024: no purchases and 3 sales on the market.
The latest filing, published on 31 May 2024, reports a transaction in Shockwave Medical, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 63 declarations